Oruka Therapeutics, Inc. Common Stock ORKA
$96.87
+0.23%
at last close
Analyst Consensus
- Consensus Rating
- Buy (9 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $128.78
- Implied Upside
- +32.9%
- Price Target Range
- $72.00 – $200.00
- Analysts (12 mo)
- 9
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-11-10 | BTIGJulian Harrison |
Reiterates | Buy | $151 |
| 2026-10-27 | GuggenheimYatin Suneja |
Reiterates | Buy | $200 |
| 2026-10-27 | WedbushMartin Fan |
Reiterates | Outperform | $165 |
| 2026-10-19 | BTIGJulian Harrison |
Reiterates | Buy | $151 |
| 2026-09-24 | WedbushMartin Fan |
Reiterates | Outperform | $165 |
| 2026-09-24 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $120 |
| 2026-09-03 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $120 |
| 2026-08-11 | GuggenheimYatin Suneja |
Reiterates | Buy | $200 |
| 2026-08-11 | WedbushMartin Fan |
Reiterates | Outperform | $165 |
| 2026-08-11 | BTIGJulian Harrison |
Reiterates | Buy | $151 |
| 2026-08-03 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $120 |
| 2026-07-13 | BTIGJulian Harrison |
Reiterates | Buy | $151 |
| 2026-07-01 | UBSMichael Yee |
Maintains | Buy | $100 → $130 |
| 2026-06-23 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $120 |
| 2026-05-18 | HC Wainwright & Co.Mitchell S. Kapoor |
Reiterates | Buy | $120 |
| 2026-05-14 | BTIGJulian Harrison |
Reiterates | Buy | $151 |
| 2026-04-29 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $75 → $120 |
| 2026-04-28 | UBSMichael Yee |
Maintains | Buy | $75 → $100 |
| 2026-04-28 | BarclaysEtzer Darout |
Maintains | Overweight | $78 → $160 |
| 2026-04-27 | BTIGJulian Harrison |
Maintains | Buy | $78 → $151 |
| 2026-04-15 | WedbushMartin Fan |
Maintains | Outperform | $45 → $85 |
| 2026-04-13 | GuggenheimYatin Suneja |
Reiterates | Buy | $125 |
| 2026-04-13 | BTIGJulian Harrison |
Maintains | Buy | $73 → $78 |
| 2026-04-13 | HC Wainwright & Co.Mitchell S. Kapoor |
Maintains | Buy | $40 → $70 |
| 2026-04-09 | GuggenheimYatin Suneja |
Reiterates | Buy | $125 |
| 2026-04-07 | BarclaysEtzer Darout |
Maintains | Overweight | $50 → $78 |
| 2026-04-06 | UBSMichael Yee |
Maintains | Buy | $50 → $75 |
| 2026-04-06 | GuggenheimYatin Suneja |
Maintains | Buy | $60 → $125 |
| 2026-03-16 | Leerink PartnersDavid Risinger |
Maintains | Outperform | $58 → $86 |
| 2026-03-13 | BarclaysEtzer Darout |
Maintains | Overweight | $48 → $50 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $96.87
- Market Cap
- $6.40 billion
- 52-Week Range
- $15.00 – $115.52
- Average Volume
- 986K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.